Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures
| Image |  |
|---|---|
| Description | scientific article published on 12 April 2018 |
| Author/s |
author: John D Hainsworth John V Heymach |
| Publication date | April 12, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |